Antimicrobial Peptide design for Klebsiella Pneumonia

Klebsiella Pneumonia (K. Pneumonia) is a pathogen responsible for numerous infections that can be deadly to humans. Recent surges in antibiotic resistance have prompted the need for novel forms of treatment, one of which is the use of antimicrobial peptides (AMPs) for combating bacteria. Several databases were used to gather data for our process, including GRAMPA and ADP3. Predictive software AlphaFold3, CAMPR3, CAMPR4, and AXPEP were used to convert known AMP into a brand new peptide that can be used to destroy K. Pneumonia. This peptide has a low probability of toxicity, and high AMP probability, with real potential to cure those afflicted with K. Pneumonia. However, further research into its capabilities and potential harmful effects is required.